Health Trials

Tofacitinib in Juvenile Idiopathic Arthritis

ConditionJuvenile Idiopathic Arthritis (JIA)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorConsorci Sanitari de l'Alt Penedès i Garraf

About this trial

This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Tofacitinib

Treatment groups

58 Participants
are divided into 1 treatment group

Locations

3
Hospital Sant Joan de Déu Barcelona BarcelonaBarcelona, Spain
Corporació Sanitària Parc Taulí de Sabadell SabadellBarcelona, Spain
Hospital de Vilafranca08720, Vilafranca del PenedèsBarceona, Spain

Sponsors and collaborators

Consorci Sanitari de l'Alt Penedès i Garraf

Lead sponsor

Source ClinicalTrials.gov